HG

Hinaben Ghanshyambhai Patel

Active Director Director DIN 08075705
DIN 08075705 First appointment Feb 2018 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Hinaben Ghanshyambhai Patel

Data last updated:

Hinaben Ghanshyambhai Patel is a Director at Vaidu Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages.

DIN 08075705
Primary Designation Director
Industry Food And Beverages
First Appointment 27 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20182018Active

Board colleagues of Hinaben Ghanshyambhai Patel

Directorship timeline

Open interactive timeline →
Vaidu Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hinaben Ghanshyambhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hinaben Ghanshyambhai Patel

Hinaben Ghanshyambhai Patel currently holds 1 directorship: Vaidu Pharmaceuticals Private Limited (Director, since 27 Feb 2018).

Hinaben Ghanshyambhai Patel was first appointed on 27 Feb 2018 as Director at Vaidu Pharmaceuticals Private Limited.

The current boards of Hinaben Ghanshyambhai Patel's companies include Ghanshyambhai Bhikhabhai Patel (Vaidu Pharmaceuticals Private Limited), Niranjanaben Girishkumar Patel (Vaidu Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available